Babcock International's stock slid 4.0% after the defence and engineering group published its FY26 audited results, which included a confirmed £140 million non-recurring charge related to its Type 31 frigate programme. That charge reduced headline reported operating profit to £293 million, even though the company's underlying performance comfortably exceeded consensus assumptions.
The results and an accompanying investor presentation were released at 09:00 BST, prompting a swift market reaction that saw the shares touch a session low of 993p before they recovered modestly to trade around 1,004p. Market participants described the move as a classic sell-on-the-news response to the audited confirmation of an anticipated contract-related cost.
Underneath the headline adjustment, operational results were markedly stronger. On an organic constant-currency basis, revenue increased 8% to £5.18 billion. Underlying EBITA rose 19% to £433 million, and underlying free cash flow jumped 71% to £261.8 million. The board signalled capital return intentions by announcing a new £200 million share buyback programme and increasing the full-year dividend by 15% to 7.5p per share.
Crucially, the audited results confirmed that cash costs associated with the fixed-price Type 31 contract are still expected to flow through the remainder of the programme. That keeps execution risk in focus for investors who had hoped the audit might draw a cleaner line under the issue.
The company is also undergoing a leadership transition. David Lockwood is retiring and Harry Holt has formally joined the board, representing a change in the executive team that investors will monitor as the company executes against backlog and contract delivery.
The share price move appeared to be company-specific rather than a response to broader market weakness. The FTSE 100 edged modestly higher on the day, while other UK defence names have experienced valuation pressure in recent weeks. The report notes that BAE Systems and Rolls-Royce have seen their valuations come under strain, and that the wider UK defence cohort has retreated from earlier 2026 highs amid concern that elevated price-to-earnings multiples had moved ahead of near-term earnings delivery.
In short, the market had expected a largely clean set of audited results but instead received confirmation that the Type 31 fixed-price contract will continue to weigh on reported earnings and cash flows for the foreseeable term. The company's underlying financial performance - and a contract backlog of £9.8 billion with defence and nuclear representing around 80% of group revenue - underpins a credible longer-term case. Nevertheless, near-term investor sentiment remains anchored to the contract charge overhang and the transition to new leadership.
Key context and figures
- Headline reported operating profit: £293 million (after a £140 million non-recurring Type 31 charge)
- Organic constant-currency revenue: up 8% to £5.18 billion
- Underlying EBITA: up 19% to £433 million
- Underlying free cash flow: up 71% to £261.8 million
- Board actions: £200 million share buyback; dividend raised 15% to 7.5p per share
- Contract backlog: £9.8 billion; defence and nuclear represent about 80% of group revenue